Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Historical Holders from Q3 2020 to Q3 2025

Symbol
OM on Nasdaq
CUSIP
690145107
Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
266M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
177K
Holdings value
$2.5M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
3
Number of buys
2
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Durable Capital Partners LP 9.9% $155M 26.6M Durable Capital Partners LP Jan 3, 2025
PFM Health Sciences, LP 9.4% $145M 25M PFM Health Sciences, LP Mar 10, 2025
PERCEPTIVE ADVISORS LLC 9.5% $32.7M 5.63M Perceptive Advisors LLC Jan 8, 2025
FMR LLC 7% $21.3M 3.67M FMR LLC Dec 31, 2024
VANGUARD GROUP INC 4.96% $15.2M 2.61M The Vanguard Group Dec 31, 2024
Alyeska Investment Group, L.P. 9.61% $9.9M 1.7M Alyeska Investment Group, L.P. Mar 31, 2025

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 177K $2.5M +$2.01M $14.12 3
2025 Q2 34.7K $668K +$196K $21.73 2
2025 Q1 24.6K $272K -$26.8M $5.81 2
2024 Q4 21.1M $23.4M -$3.64M $1.11 73
2024 Q3 26.1M $17.6M -$39.7M $0.68 76
2024 Q2 48.6M $187M -$3.41M $3.85 117
2024 Q1 50M $111M -$22.5M $2.22 108
2023 Q4 52.5M $284M -$59.7M $5.41 135
2023 Q3 53M $577M -$2.37M $10.88 148
2023 Q2 53M $1.16B +$26M $21.87 152
2023 Q1 52M $957M +$47.1M $18.40 158
2022 Q4 49M $1.26B +$1.9M $25.82 147
2022 Q3 47.7M $759M -$60.8M $15.93 130
2022 Q2 48.5M $721M -$164M $14.86 144
2022 Q1 51.3M $2.33B +$124M $45.40 149
2021 Q4 48.6M $2.24B -$207M $46.09 154
2021 Q3 50.7M $2.51B +$216M $49.44 138
2021 Q2 46.3M $2.31B +$391M $49.98 126
2021 Q1 38.4M $2.09B +$50.1M $54.39 109
2020 Q4 37.4M $2.09B +$69.5M $56.84 110
2020 Q3 36.2M $1.76B +$1.76B $50.00 85